Condition
Early Psychosis
ClinicalTrials.gov condition label
Clinical trials
13 shownBRAVE Program to Improve Safety and Reduce Violence Risk in Early PsychosisNCT07417904 · 2026-07-02
RECRUITINGDigital Strategies to Advance Help-Seeking - Aim 3NCT06774417 · 2026-02-02
RECRUITINGState Representation in Early Psychosis 2NCT07834203 · 2025-10-15
RECRUITINGDigital Strategies to Advance Help-Seeking Aim 1 and 2NCT06774430 · 2025-04-07
RECRUITINGBiomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesNCT06740383 · 2023-01-01
RECRUITINGEffects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early PsychosisNCT04411225 · 2022-06-01
RECRUITINGPerception and Integration of Sensory Information in the Early Stages of PsychosisNCT07446569 · 2026-04-01
NOT_YET_RECRUITINGPSYCHE Cognitive Remediation & Social Recovery StudyNCT06032182 · 2023-03-01
UNKNOWNEffects of an Acceptance-based Medication Adherence Therapy for Recent-onset PsychosisNCT06192602 · 2023-02-01
ACTIVE_NOT_RECRUITINGIntervention to Improve Coping With Negative Emotions in Patients With Psychosis (Feel-Good-Study)NCT04592042 · 2021-01-08
COMPLETEDEffect of a Peer-led Self-management Program for Recent-onset PsychosisNCT04166019 · 2020-12-01
COMPLETEDR33: Levetiracetam in Early PsychosisNCT04317807 · 2020-08-27
COMPLETEDDecision-making and Decision Support Among Emerging Adults With First Episode PsychosisNCT04373590 · 2019-02-27
COMPLETEDCommon interventions
AIM_ATBEHAVIORAL1behavioral tasksBEHAVIORAL1BRAVE (Behavioral Response Against Violence Engagement)BEHAVIORAL1Cannabidiol oral solutionDRUG1Comprehensive Assessment of At Risk Mental States (CAARMS)DIAGNOSTIC_TEST1CPGBEHAVIORAL1CRESTR ControlBEHAVIORAL1CRESTR InterventionBEHAVIORAL1Decision aidBEHAVIORAL1Digital nudgeOTHER1ElectroretinographyDEVICE1Feel-Good- GroupBEHAVIORAL1Levetiracetam PillDRUG1Neuropsychological testsBEHAVIORAL1Peer-led self-management programBEHAVIORAL1PlaceboOTHER1Psycho-education groupBEHAVIORAL1TAUBEHAVIORAL1Treatment As Usual (TAU)OTHER1Usual careBEHAVIORAL1
Leading sponsors
Chinese University of Hong Kong2Columbia University2Beth Israel Deaconess Medical Center1Centre Psychothérapique de Nancy1Howard University1National University of Ireland, Galway, Ireland1NYU Langone Health1Philipps University Marburg1Temple University1University of California, San Diego1University of Minnesota1
Trial status mix
RECRUITING6
COMPLETED4
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
UNKNOWN1
Phase mix
NA7
EARLY_PHASE11
PHASE21
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.